For the pilot, the drug will be made available in areas with the highest transmission rates, starting with Douala, according to health officials.
Feel free to get in touch with us.
Regarding news, email: editor@tell.co.ke
For all others, email: info@tell.co.ke
News you can trust
Tell is a totally independent Kenyan-based news and current affairs media house. Tell delivers in-detail journalism for critical audiences interested in finance/economy, humanity, progress and governance.
We are seasoned journalists story-telling in written format and recorded/produced/digital media.
